Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com.
About Coria Laboratories, Ltd.
Coria Laboratories, Ltd. is a rapidly growing pharmaceutical company specializing in research, development and marketing of high-quality dermatology products for the treatment of diseases affecting the skin, hair, and nails. Coria Laboratories has a broad portfolio of branded prescription and over-the-counter dermatology products. For more information on Coria Laboratories, visit the web site at: http://www.corialabs.com.
About DFB Pharmaceuticals, Inc.
DFB Pharmaceuticals, Inc. is a privately held Texas corporation that
provides technology-driven pharmaceutical products, outsourcing services,
and licensing opportunities through its affiliate partners to the
healthcare industry worldwide. DFB's business structure is organized by
segments: Branded Pharmaceuticals, Biotechnology, and Pharmaceutical
Services. The Branded Pharmaceuticals segment includes HEALTHPOINT, Ltd.,
active in the research, development, and marketing of branded
pharmaceuticals, over-the-counter drugs, and biotech drugs for wound care
indications since 1992; and Coria Laboratories, Ltd., focusing on
dermatology and treatments of diseases that affect the skin, hair, and
nails. Pharmaceutical Services includes DPT Laboratories, Ltd., a Contract
|SOURCE DFB Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved